Moving towards an era of hybrid modelling: advantages and challenges of coupling mechanistic and data-driven models for upstream pharmaceutical bioprocesses-Reference-Cited by-同舟云学术

Moving towards an era of hybrid modelling: advantages and challenges of coupling mechanistic and data-driven models for upstream pharmaceutical bioprocesses

Published:2021-06 Issue: Volume:32 Page:100691
ISSN:2211-3398
Container-title:Current Opinion in Chemical Engineering
language:en
Short-container-title:Current Opinion in Chemical Engineering

Author:

Tsopanoglou Apostolos,Jiménez del Val Ioscani^ORCID

Funder

Science Foundation Ireland

Publisher

Elsevier BV

Subject

General Energy

Reference46 articles.

1. Biopharmaceutical benchmarks 2018;Walsh;Nat Biotechnol,2018

2. Therapeutic glycoprotein production in mammalian cells;Lalonde;J Biotechnol,2017

3. The increasingly human and profitable monoclonal antibody market;Grilo;Trends Biotechnol,2019

4. Antibodies to watch in 2021;Kaplon;mAbs,2021

5. Recombinant antibody production in CHO and NS0 cells: differences and similarities;Dhara;BioDrugs,2018

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BayesianSSA: a Bayesian statistical model based on structural sensitivity analysis for predicting responses to enzyme perturbations in metabolic networks;BMC Bioinformatics;2024-09-10

2. A neural ordinary differential equation model for predicting the growth of Chinese Hamster Ovary cell in a bioreactor system;Biotechnology and Bioprocess Engineering;2024-09-01

3. The future of digital applications in pharmaceutical operations;Current Opinion in Chemical Engineering;2024-09

4. End-to-end process flowsheet modeling for biopharmaceutical production: current state and future potential;Current Opinion in Chemical Engineering;2024-09

5. Advanced methodologies for model-based optimization and control of pharmaceutical processes;Current Opinion in Chemical Engineering;2024-09